Amanda Galgay
Public Communications Contact presso TANGO THERAPEUTICS, INC.
Profilo
Amanda Brown Galgay is currently the Vice President of Communications at Exscientia AI Ltd.
and the Senior Vice President of Corporate Communications at Tango Therapeutics, Inc. She previously worked as the Vice President of Communications at Exscientia Plc from 2021 to 2022, the Vice President of Corporate & Investor Communications at Pear Therapeutics (US), Inc. from 2018 to 2019, and the Vice President of Corporate Affairs at Ohana Biosciences, Inc. from 2019 to 2021.
Ms. Galgay obtained her undergraduate degree from the University of Missouri Extension.
Posizioni attive di Amanda Galgay
| Società | Posizione | Inizio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Public Communications Contact | - |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Public Communications Contact | - |
Precedenti posizioni note di Amanda Galgay
| Società | Posizione | Fine |
|---|---|---|
| EXSCIENTIA PLC | Public Communications Contact | 31/12/2022 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2021 |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Contatto Relazioni con gli Investitori | 01/08/2019 |
Formazione di Amanda Galgay
| University of Missouri Extension | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
- Borsa valori
- Insiders
- Amanda Galgay
